Adapting Trials (In a Hurry) for Remote Assessment: ISCTM / FDA and EMA Webinars

Public Access – In order to serve the field at large during this time of unusual and trying circumstances, the ISCTM has made the following recent webinars available to the public.

3 April – Webinar 1 – Identifying some of the key questions
17 April – Webinar 2 – FDA responses and discussion
15 May – Webinar 3 – EMA perspectives with FDA participation

Innovative Technologies Workgroup held an ad hoc call on 3 April to discuss adapting trials for remote assessment in light of the impact of COVID-19 on clinical trials and subsequent increased interest in remote assessments. The meeting was attended by visitors from the FDA Office of Medical Policy, Division of Clinical Outcome Assessments, and Division of Psychiatry who participated in the discussion.  During the course of the 3 April discussion, many questions were raised, and the FDA participants agreed to address those questions on a second call held Friday 17 April.
On Friday 15 May a third discussion was held with regulatory panelists from the EMA and EU network as well as FDA to focus on European regulatory perspectives. Differences between EU and US regulatory considerations were noted. 

Call for Session Proposals

Session proposals are now being accepted for the February 2021 meeting in Washington DC.

ISCTM Session Proposal Submission Form

Upcoming Calendar

9 July 2020 – Poster Submission: 2020 Autumn Conference

21-25 September – 2020 Autumn Conference
Virtual Conference

17-19 February – 2021 – 17th Annual Scientific Meeting
The Grand Hyatt, Washington DC

19-20 February 2020 – ISCTM/ASCP Advanced CNS Clinical Trials Course
Washington, DC

30 September – 2 October – 2021 Autumn Conference
Includes joint day with ECNP
The Pestana Palace, Lisbon, Portugal